Joan Janulis is now senior VP of global regulatory affairs at Slayback Pharma LLC.
Genesis Drug Discovery & Development appointed Olesia Buiakova, M.D., Ph.D., as chief scientific officer.
As drug prices fall under increased scrutiny, payers and regulators are targeting some key initiatives that could change the dynamic of pharmacy benefit management over the next 12 months. These emerging trends point to potentially rougher terrain for drugmakers looking to increase market share as payers take a more active role in enforcing formularies.
Healthcare providers, payers, and pharma companies are not making significant strides toward consumer centricity despite increasing demands and competition for healthcare dollars, according to new research by the global brand and marketing consultancy Prophet.
Med Ad News spoke with the authors of Prophet’s study of customer centricity in health care to find out more about their research and recommendations.
Health care continues to be one of the top issues that voters want to hear candidates talk about during their 2018 congressional campaigns, according to the results of Kaiser Health’s June 2018 tracking poll.
Here are the top five factors affecting drug pricing and reimbursement and evidence landscape and the top five factors affecting accelerated drug approvals landscape in 2018, according to Decision Resources Group.
Novartis launched its Galaxies of Hope app, a unique digital experience created to support the neuroendocrine tumor community.
This is a case study by TechEmergence, an artificial intelligence market research and media platform.
The CME provider Rockpointe launched the first CME-certified course ever offered on Amazon Echo through the AudioEducate platform with joint providers Potomac Center for Medical Education (PCME) and the Academy of Physicians in Clinical Research (APCR).
